4//SEC Filing
Piper Brian 4
Accession 0001192482-18-000225
CIK 0001138776other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:37 PM ET
Size
5.6 KB
Accession
0001192482-18-000225
Insider Transaction Report
Form 4
Piper Brian
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Purchase)
2018-05-14+270,000→ 270,000 totalExercise: $1.51Exp: 2028-05-14→ Common Stock (270,000 underlying)
Footnotes (1)
- [F1]The option award vests and becomes exercisable as follows (rounded up to the nearest whole share of common stock): one-third on May 14, 2019, then in 24 equal monthly installments on the 14th day of each subsequent calendar month, subject to the reporting person's continued service with the issuer.
Documents
Issuer
Aevi Genomic Medicine, Inc.
CIK 0001138776
Entity typeother
Related Parties
1- filerCIK 0001665924
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 4:37 PM ET
- Size
- 5.6 KB